ADNI releases data from genomewide study

03/18/2009 | HealthImaging.com

The Alzheimer's Disease Neuroimaging Initiative has released data from its high-density genomewide study that aims to show whether MRI and PET brain imaging as well as biomarkers such as blood and urine can be used to diagnose the disease at an early stage and accurately measure disease progression. The data "will now allow investigators to explore genetic factors related to the rate of progression of Alzheimer's disease," ADNI's principal investigator said.

View Full Article in:

HealthImaging.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
Catheter Engineer
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations